Results 181 to 190 of about 45,377 (263)

Current Knowledge on Phytoremediation Potential of Industrial Hemp (Cannabis sativa L.) for PFAS and Heavy Metal Contaminated Soils

open access: yesRemediation Journal, Volume 36, Issue 2, Spring 2026.
ABSTRACT This review synthesizes current research on the phytoremediation potential of industrial hemp (Cannabis sativa L.) for heavy metals, including arsenic, aluminium, mercury, copper, lead, cadmium, nickel, and zinc, as well as per‐ and polyfluoroalkyl substances (PFAS), commonly referred to as “forever chemicals.” A structured and transparent ...
Omid Ansari, Luca De Prato
wiley   +1 more source

Beyond Pharmacokinetics: Gaps for Rational Use of Medicinal Cannabis. [PDF]

open access: yesJ Clin Pharmacol
Lu S   +6 more
europepmc   +1 more source

Vaping and E‐Cigarettes: An Emergency Department Survey

open access: yesEmergency Medicine Australasia, Volume 38, Issue 6, December 2026.
ABSTRACT Objective To characterise vaping practices and perceptions in a non‐consecutive cohort across four Sydney Emergency Departments (EDs) prior to 2024 Australian legislative changes restricting disposable vapes. Methods An anonymous digital survey of up to 40 questions was conducted from May 2023 to January 2024 in patients and visitors aged > 14 
Christopher Lycett   +5 more
wiley   +1 more source

Prenatal THC Exposure Differentially Alters Gut Physiology and Microbiota in Stress-Resilient and Vulnerable Mice. [PDF]

open access: yesPharmaceuticals (Basel)
Mari M   +12 more
europepmc   +1 more source

Perceived Impacts and Predictors of Cannabis Products Used by Patients with Rheumatologic Conditions in Alberta, Canada: A Multivariable Analysis of Cross‐Sectional Survey Data

open access: yesArthritis Care &Research, Volume 78, Issue 11, Page 1791-1800, November 2026.
Objective This study aimed to characterize cannabis product choices (cannabinoid content and formulation) among patients with rheumatologic conditions and their associations with patient factors, patient‐reported perceived side effects, and positive impacts.
Susan Zhang   +10 more
wiley   +1 more source

Evaluation of Phytocannabinoids as Antitumor Agents against Ovarian Cancer Cells in Combination with Carboplatin. [PDF]

open access: yesACS Omega
Warter U   +7 more
europepmc   +1 more source

Neurotransmitter‐Defined Degeneration Patterns in Sporadic and C9orf72‐Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems—Implications for Therapy Development

open access: yesAnnals of Neurology, Volume 100, Issue 5, Page 948-961, November 2026.
Objective Amyotrophic lateral sclerosis (ALS) has a markedly distinctive clinical and neuroradiological signature, with the preferential involvement of specific brain networks and the apparent sparing of others. The molecular underpinnings of the strikingly selective anatomical vulnerability have not been fully elucidated to date despite the potential ...
Marlene Tahedl   +10 more
wiley   +1 more source

A Safe Battery Casing for a Hybrid Battery System Consisting of Lithium‐Ion High‐Power and High‐Energy Cells in Marine Applications

open access: yesEnergy Technology, Volume 14, Issue 11, November 2026.
A versatile battery module platform houses either high‐energy NMC (155 Ah) or high‐power LTO (23 Ah) lithium‐ion cells for marine hybrid propulsion. Cell‐level failure tests guide the venting design, while a stainless‐steel–ablation hood withstands the up to 580 kW particle‐laden thermal‐runaway jet and aerogel gap fillers block propagation. Both fully
Bernd Steinhoff   +3 more
wiley   +1 more source

Cannabinoid efficacy for pain: dose, chronicity and route. [PDF]

open access: yesFront Neurosci
Ellioff KJ   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy